Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Niosomal cetirizine shows promise for better alopecia treatment by targeting hair follicles effectively.

Nilotinib can cause generalized keratosis pilaris.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Cepharanthine could be a strong antiviral against COVID-19.

New compounds show promise as nonsteroidal treatments for hair loss.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Cetuximab can cause skin cysts after acne-like eruptions.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Lespedeza cuneata extract may help treat enlarged prostate.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Cedrol may help treat inflammatory bowel disease by improving gut health and function.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

ECM1-modified stem cells can effectively treat liver cirrhosis.